Introducing BIOJUVE™ Living Skin Biome Care
Crown Aesthetics expands its portfolio with BIOJUVE™ and celebrates its fifth anniversary with SkinPen® Precision
Crown Aesthetics is staking new ground in the aesthetics and cosmetic research space with the exciting new launch of BIOJUVE™.
The company, led by the flagship product SkinPen® Precision, has expanded its distribution to more than 48 countries
worldwide and is growing fast. Jeff Bedard, founder, president and CEO of Crown Laboratories, Inc., said, “We are extremely proud of our journey into aesthetics over the past five years. We believe there is still a tremendous opportunity for us in the
aesthetic market, and we expect to expand our portfolio meaningfully in the years ahead.” Crown is generating excitement with the imminent launch of the revolutionary BIOJUVE™ line in Europe. As pioneers of innovation, this latest product introduction is poised to create a significant impact.
Figure 1: Results from the BIOJUVE™ clinical study
on a female patient, 57 years of age, Fitzpatrick skin type I.1 (Left to right) Results shown at baseline, week 1, week 4 and week 8. Results may vary.
Figure 2: Results from the BIOJUVE™ clinical study on a female patient, 56 years of age, Fitzpatrick skin type IV.1 Results shown at baseline, week 1, week 4 and week 8. Results may vary
SkinPen Precision celebrates five years
CSkinPen Precision was the world’s first microneedling pen to achieve FDA clearance 2018 and is available in 48 countries. It utilises collagen induction therapy to deliver medical aesthetic treatments through controlled micro-injuries to the skin.3-5 SkinPen creates up to three million micro channels in a 30-minute treatment, eliciting the body’s natural wound-healing cascade.3-5 This process begins with injury/inflammation, progresses to tissue proliferation and ultimately results in tissue remodelling, including new collagen and elastin.3-5
Created by pioneering skin scientists and endorsed by internationally recognised boardcertified dermatologists, BIOJUVE™ is the latest in natural, skin biome innovation. The microbial powerhouses within the patented Xycrobe™ technology naturally produce and deliver around the clock Bioessentials™ such as proteins, polypeptides and antioxidants to optimise skin health and vitality.2 While conventional skincare lines have primarily focused on skin cells, recent studies underscore the significance of nurturing the skin’s microbiome. Much like the crucial role of the gut microbiome in overall wellbeing, the skin’s microbiome plays a pivotal part in maintaining skin health. Leveraging its unique Xycrobe™ Technology, BIOJUVE™ takes centre stage in cultivating a thriving microbiome, paving the way for skin health that exudes vitality and youthfulness. Dr Thomas M. Hitchcock, chief science officer at Crown Laboratories, Inc., commented, “Crown’s significant investment in skin biome research proves our deep commitment to skin science for life.
We’ve spent the last decade developing the Xycrobe™ technology and formulating it into the BIOJUVE™ brand products, with the philosophy that human skin is an ecosystem and should be cared for as such.” He continued, “We have found that this holistic approach to caring for the skin biome (including the skin, skin microbiome and skin environment) goes beyond traditional skincare and can vastly improve the skin biome’s overall health and beauty. This is reflected in our pre-clinical and clinical research published in The Journal of Cosmetic Dermatology last November.1 We are proud to be an innovator in the skin biome-care space and feel that BIOJUVE™ will be the leading solution on the market for this emerging field.” BIOJUVE™ is available from aesthetic providers across the UK, Ireland and Germany.
